DANIEL BRADBURY - 24 Jun 2025 Form 4 Insider Report for Vivani Medical, Inc. (VANI)

Role
Director
Signature
/s/ Adam Mendelsohn, Attorney-in-fact
Issuer symbol
VANI
Transactions as of
24 Jun 2025
Net transactions value
+$44,347
Form type
4
Filing time
26 Jun 2025, 19:23:09 UTC
Previous filing
23 May 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BRADBURY DANIEL Director C/O VIVANI MEDICAL, INC., 1350 S. LOOP ROAD, ALAMEDA /s/ Adam Mendelsohn, Attorney-in-fact 26 Jun 2025 0001236397

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VANI Non-Qualified Stock Option (right to buy) Award $44,621 +35,135 $1.27 35,135 24 Jun 2025 Common Stock 35,135 $1.27 Direct F1, F2
transaction VANI Non-Qualified Stock Option (right to buy) Disposed to Issuer $275 -237 -0.47% $1.16 49,822 01 Jan 2025 Common Stock 237 $1.16 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

DANIEL BRADBURY is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2 The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.
F3 Reflects an adjustment to a previously reported amount grant on 01/01/2025 from 50,059 to 49,822 due to a clerical error.
F4 The option will vest one-fourth at the end of each calendar quarter following the grant date, subject to continued service through each such date.

Remarks:

Exhibit 24 Power of Attorney